Modern management of hypertension and heart failure: evidence and practice
Open Access
- 1 September 2000
- Vol. 84 (90001) , 35i-38
- https://doi.org/10.1136/heart.84.suppl_1.i35
Abstract
The relation between rising blood pressure and cardiovascular mortality is well known. The closer relation between systolic pressure and risk of cardiac events, however, is still underestimated. There is a fivefold increase in cardiovascular risk at high systolic pressures compared to the threefold increase with high diastolic pressure.2 It is still the case that many physicians concentrate principally on lowering diastolic pressure while not achieving systolic blood pressure targets.Keywords
This publication has 10 references indexed in Scilit:
- Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart FailureCirculation, 1999
- Guidelines for management of hypertension: report of the third working party of the British Hypertension SocietyJournal of Human Hypertension, 1999
- Incidence and aetiology of heart failure; a population-based studyEuropean Heart Journal, 1999
- The global burden of disease, 1990–2020Nature Medicine, 1998
- Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trialThe Lancet, 1998
- Blood pressure screening, management and control in EnglandJournal Of Hypertension, 1998
- Why are angiotensin converting enzyme inhibitors underutilised in the treatment of heart failure by general practitioners?International Journal of Cardiology, 1997
- New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit.1996
- Evidence of inadequate investigation and treatment of patients with heart failure.Heart, 1994
- Validity of clinical diagnosis of heart failure in primary health careEuropean Heart Journal, 1991